Influenza
-
healthThe Vaccines That Defined American Public Health Over 250 Years
A clinical review of the 17 most transformative vaccines in U.S. history, from the eradication of smallpox to the rapid development of the COVID-19 mRNA platform.
-
healthStripe Founders Commit $500 Million to Nonprofit Intercept to End Respiratory Viruses
Patrick and John Collison launch Intercept, a $500 million nonprofit aiming to cure the common cold and influenza, separate from Stripe's payments business.
-
worldFlu Outbreak Hits Texas Air Force Base Following End of Vaccine Mandate
Over 150 recruits at Lackland Air Force Base contracted influenza weeks after Secretary Pete Hegseth ended mandatory vaccinations, prompting the Pentagon to grant emergency policy exceptions.
-
healthConjugate Vaccine Technology Accelerates Influenza Antibody Response
Preclinical study shows conjugate vaccine platform iBoost enhances speed, strength, and diversity of antibody responses against influenza viruses.
-
healthEurope Approves Moderna's First mRNA Flu-COVID Vaccine, mCOMBRIAX
Moderna's mCOMBRIAX, the world's first mRNA combo vaccine for flu and COVID-19, receives European authorization, offering a simplified immunization option.
-
healthCanada Sees Surge in Respiratory Hospitalizations Amid Declining Vaccine Rates
Thousands hospitalized for COVID-19, flu, and RSV in Canada. Experts urge increased vaccination to ease strain on healthcare systems.
-
healthDisease Season Forecastability: Some Are Harder to Predict
New research reveals infectious disease forecasting difficulty varies by season, pathogen, and population size, impacting hospital admission predictions.
-
healthStanford Nasal Spray Vaccine Shows Promise for Multi-Disease Protection
A groundbreaking nasal spray vaccine developed at Stanford Medicine could offer simultaneous protection against COVID-19, flu, and pneumonia, potentially transforming respiratory illness prevention.